Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization

Journal of Neurosurgery

Volumn 100, Issue 2 SUPPL., 2004, Pages 187-193

  Tong, Carol Y K ^b   Hui, Angela B Y ^b   Yin, Xiao Lu ^b   Pang, Jesse C S ^b   Zhu, Xian Lun ^b   Poon, Wai Sang ^b   Ng, Ho Keung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

Array based comparative genomic hybridization; Medulloblastoma; Oncogene

Indexed keywords

MOLECULAR MARKER;

ADOLESCENT; ADULT; ARRAY BASED COMPARATIVE GENOMIC HYBRIDIZATION; ARTICLE; CARCINOGENESIS; CHILD; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 16Q; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 2P; CHROMOSOME 3P; CHROMOSOME 5P; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CSE1L GENE; D17S1670 GENE; DNA MICROARRAY; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENETIC ANALYSIS; GENOME; GENOME WIDE SURVEY; HUMAN; HUMAN TISSUE; MALE; MDM2 GENE; MEDULLOBLASTOMA; MET GENE; ONCOGENE; ONCOGENE C MYB; ONCOGENE C MYC; PGY1 GENE; PIK3CA GENE; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0942290729     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/ped.2004.100.2.0187     Document Type: Article

References (44)

1. Aldosari N, Bigner SH, Burger PC, et al: MYCC and MYCN 1 oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group. Arch Pathol Lab Med 126:540-544, 2002
2. Avet-Loiseau H, Venuat AM, Terrier-Lacombe MJ, et al: Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children. Br J Cancer 79:1843-1847, 1999
3. Badiali M, Pession A, Basso G, et al: N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplification. Tumori 77:118-121, 1991
4. Batra SK, McLendon RE, Koo JS, et al: Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neurooncol 24:3945, 1995
5. Bayani J, Zielenska M, Marrano P, et al: Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping. J Neurosurg 93:437-448, 2000
6. Biegel JA, Rorke LB, Packer RJ, et al: Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer 1:139-147, 1989
7. Bigner SH, Mark J, Friedman HS, et al: Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet 30:91-101, 1988
8. Bigner SH, McLendon RE, Fuchs H, et al: Chromosomal characteristics of childhood brain tumors. Cancer Genet Cytogenet 97:125-134, 1997
9. Blaeker H, Rasheed BK, McLendon RE, et al: Microsatellite analysis of childhood brain tumors. Genes Chromosomes Cancer 15:54-63, 1996
10. Brinkmann U, Gallo M, Polymeropoulos MH, et al: The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines. Genome Res 6:187-194, 1996
11. Cogen PH, McDonald JD: Tumor suppressor genes and medulloblastoma. J Neurooncol 29:103-112, 1996
12. Collins VP, Ichimura K, Liu L: The expression of the EGF receptor family and their ligands in human medulloblastomas. Neuropathol Appl Neurobiol 28:156-157, 2002 (Abstract)
13. du Manoir S, Schrock E, Bentz M, et al: Quantitative analysis of comparative genomic hybridization. Cytometry 19:27-41, 1995
14. Eberhart CG, Kratz JE, Schuster A, et al: Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol 12:36-44, 2002
15. Fuller GN, Bigner SH: Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat Res 276: 299-306, 1992
16. Giangaspero F, Bigner SH, Kleihues P, et al: Medulloblastoma, in Kleihues P, Cavenee WK (eds): Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000, pp 129-137
17. Giangaspero F, Rigobello L, Badiali M, et al: Large-cell medulloblastomas. A distinct variant with highly aggressive behavior. Am J Surg Pathol 16:687-693, 1992
18. Gilbertson R, Wickramasinghe C, Heman R, et al: Clinical and molecular stratification of disease risk in medulloblastoma. Br J Cancer 85:705-712, 2001
19. Gilhuis HJ, Anderl KL, Boerman RH, et al: Comparative genomic hybridization of medulloblastomas and clinical relevance: eleven new cases and a review of the literature. Clin Neurol Neurosurg 102:203-209, 2000
20. Herms JW, Behnke J, Bergmann M, et al: Potential prognostic value of C-erbB-2 expression in medulloblastomas in very young children. J Pediatr Hematol Oncol 19:510-515, 1997
21. Hui AB, Lo KW, Yin XL, et al: Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab Invest 81:717-723, 2001
22. Hui AB, Pang JCS, Ko CW, et al: Detection of chromosomal imbalances in growth hormone-secreting pituitary tumors by comparative genomic hybridization. Hum Pathol 30: 1019-1023, 1999
23. Jay V, Squire J, Bayani J, et al: Oncogene amplification in medulloblastoma: analysis of a case by comparative genomic hybridization and fluorescence in situ hybridization. Pathology 31:337-344, 1999
24. Korshunov A, Golanov A, Ozerov S, et al: Prognostic value of tumor-associated antigens immunoreactivity and apoptosis in medulloblastomas. An analysis of 73 cases. Brain Tumor Pathol 16:37-44, 1999
25. Leng J, Lang J, Shen K, et al: Overexpression of p53, EGFR, c-erbB2 and c-erbB3 in endometrioid carcinoma of the ovary. Chin Med Sci J 12:67-70, 1997
26. Leonard JR, Cai DX, Rivet DJ, et al: Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features. J Neurosurg 95:82-88, 2001
27. MacDonald TJ, Brown KM, LaFleur B, et al: Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 29:143-152, 2001
28. Michiels EM, Weiss MM, Hoovers JM, et al: Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization. J Pediatr Hematol Oncol 24:205-210, 2002
29. Nicholson JC, Ross FM, Kohler JA, et al: Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours. Br J Cancer 80:1322-1331, 1999
30. Nishizaki T, Harada K, Kubota H, et al: Genetic alterations in pediatric medulloblastomas detected by comparative genomic hybridization. Pediatr Neurosurg 31:27-32, 1999
31. Pomeroy SL, Tamayo P, Gaasenbeek M, et al: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-442, 2002
32. Reardon DA, Michalkiewicz E, Boyett JM, et al: Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res 57:4042-4047, 1997
33. Riou G, Mathieu MC, Barrois M, et al: c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients. Int J Cancer 95:266-270, 2001
34. Saylors RL III, Sidransky D, Friedman HS, et al: Infrequent p53 gene mutations in medulloblastomas. Cancer Res 51: 4721-4723, 1991
35. Scheurlen WG, Schwabe GC, Joos S, et al: Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J Clin Oncol 16:2478-2485, 1998
36. Shayesteh L, Lu Y, Kuo WL, et al: PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21:99-102, 1999
37. Thomas GA, Raffel C: Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors. Cancer Res 51:639-643, 1991
38. Volm M, Efferth T, Mattern J: Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. Anticancer Res 12:11-20, 1992
39. von Deimling A, Fimmers R, Schmidt MC, et al: Comprehensive allelotype and genetic analysis of 466 human nervous system tumors. J Neuropathol Exp Neurol 59:544-558, 2000
40. Wasson JC, Saylors RL 3rd, Zeltzer P, et al: Oncogene amplification in pediatric brain tumors. Cancer Res 50:2987-2990, 1990
41. Yin XL, Hui AB, Pang JC, et al: Genome-wide survey for chomosomal imbalances in ganglioglioma using comparative genomic hybridization. Cancer Genet Cytogenet 134:71-76, 2002
42. Yin XL, Pang JC, Hui AB, et al: Detection of chromosomal imbalances in central neurocytomas by using comparative genomic hybridization. J Neurosurg 93:77-81, 2000
43. Yin XL, Pang JC, Liu YH, et al: Analysis of loss of heterozygosity on chromosomes 10q, 11, and 16 in medulloblastomas. J Neurosurg 94:799-805, 2001
44. Yin XL, Pang JC, Ng HK: Identification of a region of homozygous deletion on 8p22-23.1 in medulloblastomas. Oncogene 21:1461-1468, 2002